The Advance Market Commitment scheme, formulated by the GAVI Alliance, aims to provide more vaccines to the developing world by fixing their price over a 10-year period. Is it going to deliver, what will be the result, and how did global health institutions and the big pharmaceutical companies manage to agree on such a deal?